|
|
| |
| Fast
Facts: |
| • Project
Document |
| Location: |
Southern
Sudan |
| Duration: |
1
Aug 2006 - 31July 2011 |
| Focus
area: |
Responding
to HIV/AIDS |
| Contributions(USD): |
GFATM:
5,102,221 |
| Partners: |
World
Health Organization, Southern
Sudan AIDS Commission, Ministry
of Health, UNICEF, Catholic Diocese
of Torit |
| Delivery(USD):
|
2007:
2,880,000
2008: 4,761,000 |
| Contact
person in UNDP: |
Gerard
Van Mourik, GFATM Coordinator,
gerard.vanmourik@undp.org |
|
Background
It is believed
that the civil war contributed towards
the limited spread of HIV/AIDS, as
the country was closed off from extensive
interaction with other countries.
Southern Sudan therefore experiences
a relatively low incidence of HIV/AIDS
with HIV/AIDS prevalence rates estimated
around 2.6% of the adult population.
The peace process and subsequent opening
of the Southern Sudan borders and
the interior, may well present a problem
with the potential risk of increased
HIV/AIDS transmission. There is limited
statistical evidence and data to provide
an accurate picture of the patterns
and key drivers of the epidemic in
the country.
The 2004 Sudan Millennium Development
Goals Unified Interim Report states
that since September 2002, Sudan has
faced a countrywide challenge when
it comes to HIV/AIDS. There are however
regional variations in that the prevalence
of HIV/AIDS infection is higher in
the Southern states, Eastern states,
Khartoum and White Nile State. Almost
all transmission, 94%, is the result
of heterosexual transmission, with
vertical transmission from mother
to child accounting for 2.4%. Sudan’s
situation is made even more difficult
since the epidemic has taken a grip
in neighbouring countries –
and there is free movement across
the porous borders. HIV prevalence
rates may be higher in areas that
have experienced greater population
mobility and contact with other neighbouring
countries, such as Uganda, DRC, and
Ethiopia that are believed to have
higher HIV/AIDS prevalence rates.
Objectives
The objectives of the HIV/AIDS Prevention
and Care Programme in Southern Sudan
are:
• To improve knowledge and practice
of HIV and STI preventive measures
by the general adult population, youth,
and vulnerable population sub-groups
during the 2006-2011.
• To develop and expand treatment,
care and support services for people
and families living with HIV/AIDS.
• To build the capacity of the
Southern Sudan AIDS Commission –
SSAC, NGOs and local institutions
to effectively manage and monitor
HIV/AIDS programmes.
Snapshots of the project's major achievements
• this project supported the
development of the first HIV/AIDS
Strategic Framework, HIV Policy, M&E
Framework and BCC Strategy for Southern
Sudan.
• A Southern Sudan Network of
PLHIV was formed in 2007
• As stated in the background
above, data on HIV prevalence in Sothern
Sudan is scanty, the project is supporting
sentinel surveillance in ANC clinics
across Southern Sudan and the results
will be out in the first quarter of
2010.
• This is the only project providing
ARVs for PLHIV in the entire Southern
Sudan. So far nine ART centres have
being established across Southern
Sudan and this number is expected
to double by the end of the project
in 2011. 1,684
• PLHIV are accessing ART services
from these centres against a target
of 710.
• Currently over 12,000 people
have tested for HIV in the various
VCCT centres supported by this project
and this figure is expected is increase
significantly as the project expands.
• This project also supports
safe blood practices and universal
precautions services in all transfusion
centres in Southern Sudan.
• Over 16,000 sex workers have
being reached with HIV/AIDS prevention
services
• Through this project over
75,000 youths in and out of school
have being trained on life skills
• This project also supports
training of health care providers
in VCCT, ART, STI, management
• This project contributes
to strengthening health system in
Southern Sudan through; staff recruitments,
trainings, procurement of Vehicles,
IT equipments, Laboratory equipments
and consumables, Condoms and related
drugs.
|